Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2alpha receptor

Details for Australian Patent Application No. 2011201912 (hide)

Owner Universite de Montreal Theratechnologies Inc.

Inventors Peri, Krishna G.; Polyak, Felix; Lubell, William; Thouin, Eryk; Chemtob, Sylvain

Agent Pizzeys

Pub. Number AU-A-2011201912

Parent 2003236751

Filing date 28 April 2011

Wipo publication date 19 May 2011

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

12 May 2011 Complete Application Filed

19 May 2011 Application Open to Public Inspection

  Published as AU-A-2011201912

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201913-Method for forming a bevel cut at an end of a wood member

2011201911-Storage unit for at least one device for identifying animals and/or collecting animal tissue, and corresponding method for identifying or collecting tissue